A presentation at AONN+ Annual Conference draws a connection between navigation and improved clinical trial accrual and NGS testing adherence.
2d
Life Science Instrumentation Market worth $92.5 billion by 2031 with 6.5% CAGR | MarketsandMarkets
The global Life Science Instrumentation Market, valued at US$63.4 billion in 2025, is projected to advance at a resilient CAGR of 6.5% ...
Final Phase 1b results presented at World Lung Conference highlight the potential of firmonertinib to address unmet needs in EGFR PACC mutant NSCLC Received FDA IND clearance for ARR-217, a CDH-17 ...
AZoLifeSciences on MSN
Human Pangenome Research Opens a New Chapter in Precision Medicine
In May 2023, the Human Pangenome Reference Consortium (HPRC) released the first draft of the human pangenome reference ...
Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.
3don MSN
NGS raises 2025 adjusted EBITDA guidance to $78M–$81M amid record fleet growth and dividend increase
Q3 2025 Management View Justin Jacobs, CEO, opened by stating, "NGS delivered record results again in the third quarter, extending our momentum and reinforcing the value we provide our customers ...
Despite another week of the shutdown on the horizon, the IPO calendar has a few deals scheduled for the week ahead. Read more ...
UBS Global Healthcare Conference 2025 November 10, 2025 5:00 PM ESTCompany ParticipantsBrandon Perthuis - Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback